Division of Cardiothoracic Surgery, Emory University, Atlanta, Georgia.
Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
J Surg Res. 2024 Apr;296:472-480. doi: 10.1016/j.jss.2023.12.020. Epub 2024 Feb 5.
We aimed to investigate the association between renal dysfunction at discharge and long-term survival in acute type A aortic dissection (ATAAD) patients following surgery.
From 2000 to 2021, 784 patients underwent aortic repair for an ATAAD. Patients were stratified based on creatinine (Cr) level at discharge alive or dead: normal Cr (n = 582) and elevated Cr defined as >1.3 mg/dL for males and >1.0 mg/dL for females or on dialysis at discharge (n = 202).
Preoperatively, both groups had similar rates of comorbidities except for the elevated-Cr group which had more diabetes, chronic obstructive pulmonary disease, and chronic and acute renal insufficiency. Both groups had similar open ATAAD repair procedures. Postoperative outcomes in the elevated-Cr group were significantly worse, including six times higher operative mortality (20% versus 3.4%, P < 0.0001). The landmark long-term survival after discharge alive was significantly worse in the elevated-Cr group than the normal-Cr group (10-y survival: 48% versus 69%, P = 0.0009). The elevated Cr on dialysis at discharge group had significantly worse five-year survival (40%) than the elevated Cr not on dialysis at discharge group (80%, P = 0.02) and the normal-Cr group (87%, P < 0.0001). Additionally, the elevated Cr not on dialysis had a worse five-year survival than the normal-Cr group (80% versus 87%, P = 0.02). Elevated Cr at discharge on dialysis was a significant risk factor for late mortality (hazard ratio = 4.22, 95% confidence interval: [2.07, 8.61], P < 0.0001).
Renal dysfunction at discharge was associated with significantly decreased short-term and long-term survival following open ATAAD repair. Surgeons should aggressively prevent renal dysfunction, especially new-onset dialysis, at discharge as it is correlated with significantly worse short-term and long-term outcomes.
本研究旨在探讨急性 A 型主动脉夹层(ATAAD)患者术后出院时肾功能障碍与长期生存的关系。
2000 年至 2021 年,784 例 ATAAD 患者接受了主动脉修复。根据出院时存活或死亡患者的肌酐(Cr)水平进行分层:正常 Cr 组(n=582)和升高 Cr 组(定义为男性>1.3mg/dL,女性>1.0mg/dL,或出院时透析)(n=202)。
术前,两组的合并症发生率相似,但升高 Cr 组的糖尿病、慢性阻塞性肺疾病、慢性和急性肾功能不全发生率更高。两组的开放式 ATAAD 修复手术过程相似。升高 Cr 组的术后结局明显更差,包括手术死亡率高 6 倍(20%比 3.4%,P<0.0001)。出院后存活的患者在升高 Cr 组的长期生存明显差于正常 Cr 组(10 年生存率:48%比 69%,P=0.0009)。出院时透析升高 Cr 组的五年生存率(40%)明显差于未透析升高 Cr 组(80%,P=0.02)和正常 Cr 组(87%,P<0.0001)。此外,未透析升高 Cr 组的五年生存率也差于正常 Cr 组(80%比 87%,P=0.02)。出院时透析升高 Cr 是晚期死亡的显著危险因素(风险比=4.22,95%置信区间:[2.07,8.61],P<0.0001)。
急性 A 型主动脉夹层修复术后出院时肾功能障碍与短期和长期生存率显著降低相关。外科医生应积极预防出院时的肾功能障碍,特别是新出现的透析,因为它与短期和长期结果显著恶化相关。